Former professional footballer Chris Kamara will run the 13.1-mile Great North Run to raise money for prostate cancer research, according to PA Media. The Middlesbrough-born campaigner, who played a 20-year career for clubs including Leeds United and Bradford City, will tackle the course alongside his son Jack and television presenter Ben Shephard. Prostate Cancer Awareness … Read more
< div> According to peer-reviewed research published in July in Cancer Research, sildenafil—the active ingredient in Viagra—disrupts cancer cells’ cholesterol supply to stop the spread of metastases. Researchers at the Weizmann Institute of Science, alongside teams from the US National Cancer Institute and Clalit Health Services, found that the drug targets the protein transporting essential … Read more
Researchers at the Keck School of Medicine of USC have identified a 3D hierarchy of DNA “enhancers” that function as master switches for prostate cancer development. According to a study published in Genome Biology, these interconnected networks control gene expression, revealing potential new targets for precision cancer therapies that could move beyond current gene-specific treatments. … Read more
Men who experience early-onset hair loss before age 30 may have a 29% to 45% lower risk of developing prostate cancer, according to research published in the journal Cancer Epidemiology. While the exact biological mechanism remains unconfirmed, researchers suggest that a genetic variant in the male hormone receptor gene may influence both the development of … Read more
The NHS is expanding access to Stereotactic Ablative Radiotherapy (SABR) for prostate cancer patients, a precision treatment capable of reducing a standard 20-dose radiotherapy course to just five sessions. This rollout, reaching 48 providers across England, coincides with increased public attention on prostate health following Jeremy Clarkson’s recent disclosure of an aggressive but early-stage diagnosis, … Read more
A new blood test, Stockholm3, detected 90% of aggressive prostate cancer cases in clinical trials, outperforming the traditional prostate-specific antigen (PSA) test, which identified 74%. According to a study published in the Annals of Internal Medicine, the test could improve early detection of curable disease while reducing unnecessary biopsies and MRIs for men aged 50 … Read more
Many older adults dismiss cancer warning signs as normal aging, according to Dr. Jad Chahoud, an oncologist at the Orlando Health Cancer Institute. Symptoms such as persistent fatigue, unexplained weight loss, and bowel changes are often misattributed to stress or the natural aging process, delaying life-saving medical intervention. Medical experts emphasize that rapid declines in … Read more
The Stockholm3 blood test identifies clinically significant prostate cancer more effectively than traditional Prostate-Specific Antigen (PSA) screening, according to a study published in the Annals of Internal Medicine. Researchers at Karolinska Institutet found the new test detected 90 percent of aggressive tumors compared to 74 percent for PSA, without increasing the rate of unnecessary follow-up … Read more
Hong Kong researchers are developing non-invasive blood tests designed to detect cancer early, potentially eliminating the need for painful biopsies in the coming years. According to reports from the South China Morning Post, this technology aims to simplify the diagnostic process, which currently can take months and involve invasive procedures like the tissue sampling required … Read more
Researchers at the MUSC Hollings Cancer Center have identified a mechanism that allows prostate cancer cells to survive treatment by hijacking a protein called PIM1. According to a study published in Cancer Letters, traditional therapies that block PIM1 signaling inadvertently trigger a survival response, prompting the team to develop a “degrader” compound known as PIMTAC … Read more